Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells

Toxicological Sciences

Volumn 131, Issue 1, 2013, Pages 71-83

  Teng, Yun ^a   Manavalan, Tissa T ^a   Hu, Chuan ^a   Medjakovic, Svjetlana ^b   Jungbauer, Alois ^b   Klinge, Carolyn M ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

Androgen receptor; Breast cancer; Endocrine disruptor; Estrogen receptor; Fungicide; MicroRNA

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BICALUTAMIDE; CYCLOHEXIMIDE; DACTINOMYCIN; ENDOCRINE DISRUPTOR; FENHEXAMID; FLUDIOXONIL; FULVESTRANT; MICRORNA; MICRORNA 125B; MICRORNA 181A; MICRORNA 21; PDCD4 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL;

AMIDES; BLOTTING, WESTERN; DIOXOLES; ENDOCRINE DISRUPTORS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MCF-7 CELLS; MICRORNAS; PYRROLES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION;

EID: 84872417761     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs290     Document Type: Article

References (58)

1. Angioni, A., Porcu, L., and Dedola, F. (2012). Determination of famoxadone, fenamidone, fenhexamid and iprodione residues in greenhouse tomatoes. Pest Manag. Sci. 68, 543-547.
2. Biswas, R., and Vonderhaar, B. K. (1987). Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res. 47, 3509-3514.
3. Cabizza, M., Dedola, F., and Satta, M. (2012). Residues behavior of some fungicides applied on two greenhouse tomato varieties different in shape and weight. J. Environ. Sci. Health B 47, 379-384.
4. Casals-Casas, C., and Desvergne, B. (2011). Endocrine disruptors: From endocrine to metabolic disruption. Annu. Rev. Physiol. 73, 135-162.
5. Corcoran, C., Friel, A. M., Duffy, M. J., Crown, J., and O'Driscoll, L. (2011). Intracellular and extracellular microRNAs in breast cancer. Clin. Chem. 57, 18-32.
6. Diamanti-Kandarakis, E., Bourguignon, J. P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., and Gore, A. C. (2009). Endocrinedisrupting chemicals: An Endocrine Society scientific statement. Endocr. Rev. 30, 293-342.
7. Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J. C., Harigai, M., Samudio, I., Kladde, M. P., Vyhlidal, C., and Safe, S. (1999). Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J. Biol. Chem. 274, 32099-32107.
8. Dotzlaw, H., Leygue, E., Watson, P. H., and Murphy, L. C. (1999). Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: Relationship to steroid receptor status and regulation by progestins. Cancer Res. 59, 529-532.
9. Fillinger, S., Leroux, P., Auclair, C., Barreau, C., Al Hajj, C., and Debieu, D. (2008). Genetic analysis of fenhexamid-resistant field isolates of the phytopathogenic fungus Botrytis cinerea. Antimicrob. Agents Chemother. 52, 3933-3940.
10. Fu, X., Han, Y., Wu, Y., Zhu, X., Lu, X., Mao, F., Wang, X., He, X., Zhao, Y., and Zhao, Y. (2011). Prognostic role of microRNA-21 in various carcinomas: A systematic review and meta-analysis. Eur. J. Clin. Invest. 41, 1245-53.
11. Fujita, S., Ito, T., Mizutani, T., Minoguchi, S., Yamamichi, N., Sakurai, K., and Iba, H. (2008). miR-21 gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J. Mol. Biol. 378, 492-504.
12. Gill, P. G., Tilley, W. D., De Young, N. J., Lensink, I. L., Dixon, P. D., and Horsfall, D. J. (1991). Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: Effects of serum, estradiol, insulin, and EGF. Breast Cancer Res. Treat. 20, 53-62.
13. Gregory, R. I., Yan, K. P., Amuthan, G., Chendrimada, T., Doratotaj, B., Cooch, N., and Shiekhattar, R. (2004). The Microprocessor complex mediates the genesis of microRNAs. Nature 432, 235-240.
14. Hammes, S. R., and Levin, E. R. (2011). Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology 152, 4489-4495.
15. Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., and Olson, E. N. (2010). Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18, 282-293.
16. Hershko, D. D., Robb, B. W., Wray, C. J., Luo, G. J., and Hasselgren, P. O. (2004). Superinduction of IL-6 by cycloheximide is associated with mRNA stabilization and sustained activation of p38 map kinase and NF-kappaB in cultured Caco-2 cells. J. Cell. Biochem. 91, 951-961.
17. Horwitz, K. B., Costlow, M. E., and McGuire, W. L. (1975). MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 26, 785-795.
18. Iorio, M. V., and Croce, C. M. (2012). MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143-159.
19. JMPR. (2005). Pesticide residues in food-2005. The Joint FAO/WHO Meeting on Pesticide Residues (JMPR), Rome.
20. Klinge, C. M., Riggs, K. A., Wickramasinghe, N. S., Emberts, C. G., McConda, D. B., Barry, P. N., and Magnusen, J. E. (2010). Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription. Mol. Cell. Endocrinol. 323, 268-276.
21. Klinge, C. M. (2012). miRNAs and estrogen action. Trends Endocrinol. Metab. 23, 223-233.
22. Kotsopoulos, J., and Narod, S. A. (2012). Androgens and breast cancer. Steroids 77, 1-9.
23. Koturbash, I., Beland, F. A., and Pogribny, I. P. (2012). Role of microRNAs in the regulation of drug metabolizing and transporting genes and the response to environmental toxicants. Expert Opin. Drug Metab. Toxicol. 8, 597-606.
24. Levin, E. R. (2009). Plasma membrane estrogen receptors. Trends Endocrinol. Metab. 20, 477-482.
25. Li, T., Li, D., Sha, J., Sun, P., and Huang, Y. (2009). MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem. Biophys. Res. Commun. 383, 280-285.
26. Löffler, D., Brocke-Heidrich, K., Pfeifer, G., Stocsits, C., Hackermüller, J., Kretzschmar, A. K., Burger, R., Gramatzki, M., Blumert, C., Bauer, K., et al. (2007). Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 110, 1330-1333.
27. Lundin, K. B., Henningson, M., Hietala, M., Ingvar, C., Rose, C., and Jernström, H. (2011). Androgen receptor genotypes predict response to endocrine treatment in breast cancer patients. Br. J. Cancer 105, 1676-1683.
28. Macedo, L. F., Guo, Z., Tilghman, S. L., Sabnis, G. J., Qiu, Y., and Brodie, A. (2006). Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole. Cancer Res. 66, 7775-7782.
29. Madak-Erdogan, Z., and Katzenellenbogen, B. S. (2012). Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140. Toxicol. Sci. 125, 401-411.
30. Maillot, G., Lacroix-Triki, M., Pierredon, S., Gratadou, L., Schmidt, S., Benes, V., Roche, H., Dalenc, F., Auboeuf, D., Millevoi, S., et al. (2009). Widespread estrogen-dependent repression of microRNAs involved in breast tumor cell growth. Cancer Res. 69, 8332-8340.
31. Manavalan, T. T., Teng, Y., Appana, S. N., Datta, S., Kalbfleisch, T. S., Li, Y., and Klinge, C. M. (2011). Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. Cancer Lett. 313, 26-43.
32. Matthews, J., and Gustafsson, J. A. (2006). Estrogen receptor and aryl hydrocarbon receptor signaling pathways. Nucl. Recept. Signal. 4, e016.
33. Metivier, R., Penot, G., Carmouche, R. P., Hubner, M. R., Reid, G., Denger, S., Manu, D., Brand, H., Kos, M., Benes, V., et al. (2004). Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. EMBO J. 23, 3653-3666.
34. Ni, M., Chen, Y., Lim, E., Wimberly, H., Bailey, S. T., Imai, Y., Rimm, D. L., Liu, X. S., and Brown, M. (2011). Targeting androgen receptor in estrogen receptor-negative breast cancer. Cancer Cell 20, 119-131.
35. O'Day, E., and Lal, A. (2010). MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res. 12, 201.
36. Orton, F., Rosivatz, E., Scholze, M., and Kortenkamp, A. (2011). Widely used pesticides with previously unknown endocrine activity revealed as in vitro antiandrogens. Environ. Health Perspect. 119, 794-800.
37. Rajabi, H., Jin, C., Ahmad, R., McClary, C., Joshi, M. D., and Kufe, D. (2010). Mucin 1 oncoprotein expression is suppressed by the miR-125b oncomiR. Genes Cancer 1, 62-68.
38. Ribas, J., Ni, X., Castanares, M., Liu, M. M., Esopi, D., Yegnasubramanian, S., Rodriguez, R., Mendell, J. T., and Lupold, S. E. (2012). A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts. Nucleic Acids Res. 40, 6821-6833.
39. Robinson, J. L., Macarthur, S., Ross-Innes, C. S., Tilley, W. D., Neal, D. E., Mills, I. G., and Carroll, J. S. (2011). Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO J. 30, 3019-3027.
40. Ross, J. A., and Leavitt, S. A. (2010). Analysis of the mutations induced by conazole fungicides in vivo. Mutagenesis 25, 231-234.
41. Sauermann, M., Sahin, O., Sultmann, H., Hahne, F., Blaszkiewicz, S., Majety, M., Zatloukal, K., Fuzesi, L., Poustka, A., Wiemann, S., et al. (2007). Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Oncogene 27, 1320-1326.
42. Sayed, D., He, M., Hong, C., Gao, S., Rane, S., Yang, Z., and Abdellatif, M. (2010). MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J. Biol. Chem. 285, 20281-20290.
43. Si, M. L., Zhu, S., Wu, H., Lu, Z., Wu, F., and Mo, Y. Y. (2007). miR-21-mediated tumor growth. Oncogene 26, 2799-2803.
44. Sullivan, D. A., Jensen, R. V., Suzuki, T., and Richards, S. M. (2009). Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? Mol. Vis. 15, 1553-1572.
45. Swedenborg, E., Rüegg, J., Mäkelä, S., and Pongratz, I. (2009). Endocrine disruptive chemicals: Mechanisms of action and involvement in metabolic disorders. J. Mol. Endocrinol. 43, 1-10.
46. Terao, M., Fratelli, M., Kurosaki, M., Zanetti, A., Guarnaccia, V., Paroni, G., Tsykin, A., Lupi, M., Gianni, M., Goodall, G. J., et al. (2011). Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells. J. Biol. Chem. 286, 4027-4042.
47. Thackaberry, E. A., Jiang, Z., Johnson, C. D., Ramos, K. S., and Walker, M. K. (2005). Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: Modulation of cell cycle and extracellular matrix genes. Toxicol. Sci. 88, 231-241.
48. Tilghman, S. L., Bratton, M. R., Segar, H. C., Martin, E. C., Rhodes, L. V., Li, M., McLachlan, J. A., Wiese, T. E., Nephew, K. P., and Burow, M. E. (2012). Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS ONE 7, e32754.
49. UN FAO. (2005). Pesticides Residue in Food: Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues in Food and the Environment and the WHO Core Assessment Group on Pesticide Residues Geneva, Switzerland, 20-29 September 2005, pp. 125. World Health Organization, Rome.
50. Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D.-H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., et al. (2012). Hormones and endocrine-disrupting chemicals: Low-dose effects and nonmonotonic dose responses. Endocr. Rev. 33, 378-455.
51. Waltering, K. K., Porkka, K. P., Jalava, S. E., Urbanucci, A., Kohonen, P. J., Latonen, L. M., Kallioniemi, O. P., Jenster, G., and Visakorpi, T. (2011). Androgen regulation of micro-RNAs in prostate cancer. Prostate 71, 604-614.
52. Wang, H., Tan, G., Dong, L., Cheng, L., Li, K., Wang, Z., and Luo, H. (2012). Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS ONE 7, e34210.
53. Watson, C. S., and Lange, C. A. (2005). Steadying the boat: Integrating mechanisms of membrane and nuclear-steroid-receptor signalling. EMBO Rep. 6, 116-119.
54. Weyandt, J., Ellsworth, R. E., Hooke, J. A., Shriver, C. D., and Ellsworth, D. L. (2008). Environmental chemicals and breast cancer risk-a structural chemistry perspective. Curr. Med. Chem. 15, 2680-2701.
55. Wickramasinghe, N. S., Manavalan, T. T., Dougherty, S. M., Riggs, K. A., Li, Y., and Klinge, C. M. (2009). Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res. 37, 2584-2595.
56. Wiseman, R. A. (2004). Breast cancer: Critical data analysis concludes that estrogens are not the cause, however lifestyle changes can alter risk rapidly. J. Clin. Epidemiol. 57, 766-772.
57. World Health Organization. (2006). Pesticide Residues in Food 2004: Evaluations 2004: Part II - Toxicological, pp. 461. WHO, Rome, Italy.
58. Yan, L. X., Huang, X. F., Shao, Q., Huang, M. Y., Deng, L., Wu, Q. L., Zeng, Y. X., and Shao, J. Y. (2008). MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14, 2348-2360.